Early antibody response to SARS-CoV-2
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG
Testing Method Category
Other Immuno assay
Testing Method
Maglumi 800 Analyzer (Snibe, Shenzen, China)
Testing Method - Additional Info
two step chemiluminescence immunoassay using magnetic microbeads coated with anti-human Immunoglobulins (IgM and IgG) and 2019-nCoV recombinant antigen labelled with luminescence substrate (MAGLUMI 2019-nCoV IgM and MAGLUMI 2019-nCoV IgG respectively)
Reported Performance
true positive results: 60.8% (IgM, symptomatic patients), 85.1% (IgG, symptomatic patients)
Sample Size
46 patients (77 samples)
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements